These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 7248177

  • 21. Retinoids in disorders of keratinization: their use in children.
    Ruiz-Maldonado R, Tamayo L.
    Dermatologica; 1987; 175 Suppl 1():125-32. PubMed ID: 3480249
    [Abstract] [Full Text] [Related]

  • 22. Case of pityriasis rubra pilaris with focal acantholytic dyskeratosis.
    Itoh Y, Asahina A, Kanbe M, Ito K, Nakagawa H.
    J Dermatol; 2018 Sep; 45(9):e258-e259. PubMed ID: 29512184
    [No Abstract] [Full Text] [Related]

  • 23. Biochemical changes after the oral administration of retinoid in the horny layer of patients with keratinization disorders.
    Yoshiike T, Negi M, Manabe M, Takamori K, Ogawa H.
    J Dermatol; 1982 Jun; 9(3):235-42. PubMed ID: 6752237
    [No Abstract] [Full Text] [Related]

  • 24. [Clinical and histological studies of the effect of an aromatic retinoid Ro 10-9359 on a syndrome related to Bazex paraneoplastic acrokeratosis].
    Le T, Pierard GE.
    Dermatologica; 1982 Jun; 165(6):559-67. PubMed ID: 7169131
    [No Abstract] [Full Text] [Related]

  • 25. Disseminated porokeratosis Mibelli treated with RO 10-9359. A study of two cases with ultrastructural remarks.
    Bundino S, Zina AM.
    Dermatologica; 1980 Jun; 160(5):328-36. PubMed ID: 7364142
    [Abstract] [Full Text] [Related]

  • 26. Etretinate in treatment of actinic keratosis. A double-blind crossover study.
    Moriarty M, Dunn J, Darragh A, Lambe R, Brick I.
    Lancet; 1982 Feb 13; 1(8268):364-5. PubMed ID: 6120350
    [Abstract] [Full Text] [Related]

  • 27. Treatment with an oral aromatic retinoid in linear porokeratosis.
    Pehamberger H, Konrad K.
    Dermatologica; 1980 Feb 13; 160(4):270-4. PubMed ID: 7358191
    [Abstract] [Full Text] [Related]

  • 28. Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years' experience on 23 patients.
    Katugampola RP, Finlay AY.
    Br J Dermatol; 2006 Feb 13; 154(2):267-76. PubMed ID: 16433796
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Systemic treatment of Darier's disease with an oral retinoic acid derivative Ro 10-9359 Tigason.
    Greig DE, Wishart J, Hodge JL.
    N Z Med J; 1981 Aug 12; 94(689):99-100. PubMed ID: 6944653
    [Abstract] [Full Text] [Related]

  • 32. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
    Mahrle G, Meyer-Hamme S, Ippen H.
    Arch Dermatol; 1982 Feb 12; 118(2):97-100. PubMed ID: 7059226
    [Abstract] [Full Text] [Related]

  • 33. Tigason (etretinate) in prevention of recurrence of superficial bladder tumors. A double-blind clinical trial.
    Alfthan O, Tarkkanen J, Gröhn P, Heinonen E, Pyrhönen S, Säilä K.
    Eur Urol; 1983 Feb 12; 9(1):6-9. PubMed ID: 6337054
    [Abstract] [Full Text] [Related]

  • 34. Renal impairment probably induced by etretinate.
    Cribier B, Welsch M, Heid E.
    Dermatology; 1992 Feb 12; 185(4):266-8. PubMed ID: 1477420
    [Abstract] [Full Text] [Related]

  • 35. Intractable skin disorders treated with the aromatic retinoid etretinate (Tigason). Two and a half years' experience in the Transvaal.
    Findlay GH.
    S Afr Med J; 1983 Jul 09; 64(2):54-6. PubMed ID: 6867876
    [Abstract] [Full Text] [Related]

  • 36. A case of centrolobular toxic necrosis of the liver due to aromatic retinoid--Tigason (Ro 10-9359).
    Thune P, Mørk NJ.
    Dermatologica; 1980 Jul 09; 160(6):405-8. PubMed ID: 7389973
    [Abstract] [Full Text] [Related]

  • 37. Treatment of the ichthyosis of the Sjögren-Larsson syndrome with etretinate (Tigason).
    Jagell S, Lidén S.
    Acta Derm Venereol; 1983 Jul 09; 63(1):89-91. PubMed ID: 6191505
    [Abstract] [Full Text] [Related]

  • 38. Retinoids in keratinizing diseases and acne.
    Ruiz-Maldonado R, Tamayo L.
    Pediatr Clin North Am; 1983 Aug 09; 30(4):721-34. PubMed ID: 6193480
    [No Abstract] [Full Text] [Related]

  • 39. [Tolerability of an aromatic retinoid (RO 10 9359, etretinate, Tigason, Roche). Research on its toxicity on hematopoietic, renal and thyroid functions. Interactions with the metabolism of natural retinoids].
    Fontan B, Bonafé JL, Moatti JP.
    Ann Dermatol Venereol; 1983 Aug 09; 110(1):23-31. PubMed ID: 6859752
    [Abstract] [Full Text] [Related]

  • 40. Combined treatment of psoriasis with a new aromatic retinoid (Tigason) in low dosage orally and triamcinolone acetonide cream topically: a double-blind trial.
    van der Rhee HJ, Tijssen JG, Herrmann WA, Waterman AH, Polano MK.
    Br J Dermatol; 1980 Feb 09; 102(2):203-12. PubMed ID: 6992834
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.